Stock·NYSE·Industrials
Caterpillar Inc. (CAT)
- Market cap
- $338.16B
- P/E
- 33.27
- Dividend yield
- 0.83%
- Street target
- $975.00median of 28 analysts
- 52-week range
- $510.21 $1,073.46
The short version
Where CAT stands today, in four lines, and what CleaRank Financial AI makes of it.
CAT at a glance
Caterpillar Inc. (CAT): Hold, 47/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($812.93 and $805.78).
- Earnings CAT beat estimates in 5 of its last 8 quarters, yet fell the next day after every one of them.
- Insiders Insiders sold $270.0M and bought $542K over the last 18 months.
- Valuation P/E of 33.3 against 34.0 for the Industrials sector: broadly in line with peers (-2%).
Figures as of October 16, 2026.
CleaRank Financial AI
CleaRank rates Caterpillar Inc. (CAT) Hold, with a model score of 47/100.
The analysts' outlook is the biggest contributor to the score: 15 of 28 analysts rate it a buy, and the median target is 33.4% above the price. The trend is the largest drag, with the price 9.32% below its 200-day average and 10.12% below its 50-day average. The 50-day average is $812.93 and the 200-day is $805.78. Across the past year, the price rose 36.68%.
Only on CleaRank
Figures we compute ourselves from CAT's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $730.69 is 10.1% below the 50-day simple moving average of $812.93.Price above its 200-day average ›
The price is 9.3% below the 200-day simple moving average of $805.78.50-day average above the 200-day ›
The 50-day average ($812.93) is 0.9% above the 200-day average ($805.78), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 39% of its 52-week range, between $510.21 and $1,073.46.
CAT share price
Pick a period: each tab shows how far CAT has moved over it, to the last close.
Today's trading
Where CAT sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 33.27 is 2.1% below the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 4.61 is 15.2% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $10.8B on revenue of $74.7B, a net margin of 14.5%.Beat estimates in most recent reports ›
CAT beat the EPS estimate in 5 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 0.83%, or $6.16 a share a year.
Key statistics
The headline figures for CAT.
As of October 16, 2026, CAT trades at $730.69, with a market value of $338.16B, a P/E ratio of 33.27 and a dividend yield of 0.83%.
What the numbers say
CleaRank Financial AI's reading of CAT's valuation, growth and risks.
CAT's P/E of 33.27 is 2.1% below the 34.0 median P/E of Industrials stocks, so the P/E is broadly in line with peers. Measured against sales, the company trades at 4.61 times, 15.3% above the sector median P/S of 4.0. Its market capitalisation stands at $338.2B.
With revenue growth of 24.00%, CAT is 12.3 percentage points faster than the sector median of 11.7%. The business converts sales into profit at a net margin of 14.51% and an operating margin of 22.18%. Shareholders' capital earns 56.97%, above the sector median of 17.8%, measured as return on equity. The balance sheet and payout round out the picture, with debt-to-equity of 2.33 and a trailing dividend yield of 0.83% ($6.16 a share a year).
Caterpillar's most recent report, dated August 4, 2026, showed EPS of $8.17, which beat an estimate of $6.20 by 31.77%. The share price nonetheless slipped 0.62% in the first session after the report.
CAT has beaten the EPS estimate in 5 of its last 8 reports, but the stock fell in the first session after each of those 5 beats. For this fiscal year, analysts expect average EPS of $27.20, a rise of 42.7%. Next year's average estimate is $32.42, growth of 19.2%.
CAT's daily returns have a 30-day standard deviation of 1.97%. While the price stays below its moving averages, the trend leans against holders. The stock is 31.93% under its 52-week high of $1,073.46. Over the last 18 months insiders sold $270.0M of stock and bought $542K. Sales like these are often planned in advance or made to cover tax on vesting shares, so they carry less weight than open-market purchases.
CAT against the Industrials sector
How CAT compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-2% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 6, 2025, CAT has gained 130.4% against a gain of 25.6% for XLI.
Performance against XLI
CAT and the Industrials sector fund over the same days.
Revenue and earnings
How much CAT sells, and how much of it becomes profit.
Revenue growth: Revenue grew 4.3% in FY2025 to $67.6B, from $64.8B a year earlier.
Profit margin: The net margin was 13.1% in FY2025, down from 16.6% the year before.
Profitable: CAT earned $8.9B in FY2025.
Earnings reality check
Did CAT beat what analysts expected, and how did the stock react?
Earnings record: CAT beat the analyst estimate in 5 of the last 8 quarters.
Market reaction: The stock fell in the first session after 5 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 4, 2026after close | $6.20 | $8.17 | +31.77% | -0.62% | -3.78% |
| Apr 30, 2026after close | $4.64 | $5.54 | +19.40% | -0.05% | +0.63% |
| Jan 29, 2026after close | $4.71 | $5.16 | +9.55% | -1.18% | +1.96% |
| Oct 29, 2025after close | $4.52 | $4.95 | +9.51% | -0.40% | -2.79% |
| Aug 5, 2025after close | $4.90 | $4.72 | -3.67% | -1.50% | -4.96% |
| Apr 30, 2025after close | $4.34 | $4.25 | -2.07% | +1.52% | +3.56% |
| Jan 30, 2025after close | $5.03 | $5.14 | +2.19% | -0.94% | -2.54% |
| Oct 30, 2024after close | $5.35 | $5.17 | -3.36% | -0.80% | +9.93% |
As of October 16, 2026, CAT has beaten the analyst EPS estimate in 5 of its last 8 reported quarters and fell in the first trading session after 5 of those beats; its latest report, on August 4, 2026, came in 31.77% above the estimate and the stock moved -0.62% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 32.8, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 32.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of CAT
The score, the reasoning behind it, and what could move the price next.
Caterpillar Inc. (CAT) is in a downtrend: the price of $730.69 sits 9.32% below its 200-day average of $805.78 and 10.12% below its 50-day average of $812.93. The 50-day average is still 0.89% above the 200-day, but the price has already dropped beneath the shorter average. The stock is at 39% of its 52-week range, which runs from $510.21 to $1,073.46, and sits 31.93% below that high.
A recent pullback sits inside a stronger longer record: the price fell 5.54% over the past month, fell 16.01% over the past three months and rose 36.68% over the past year. The 14-day RSI of 32.8 is in the bearish zone, above the oversold line, and the MACD line is negative. Volume in the last session ran 86.2% above its average, on a day the price fell 0.67%.
Analyst upgrade ›
Freedom Broker upgraded it to Buy from Hold on September 10, 2026.
Source: Analyst action, Freedom Broker, September 10, 2026Rating reaffirmed ›
Citigroup kept its Buy rating on October 12, 2026.
Source: Analyst action, Citigroup, October 12, 2026
Earnings beat ›
The August 4, 2026 report beat the EPS estimate by 31.77%, and the share price fell 0.62% in the first session after it.
Source: Earnings report, August 4, 2026
- Keep an eye on the two closest levels: the 20-day EMA at $794.00 overhead and the 52-week low at $510.21 underneath.
- With the 14-day RSI at 32.8, momentum reads as bearish, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
- The share price fell 0.62% in the first session after the August 4, 2026 report, even though CAT has beaten estimates in 5 of the last 8 reports.
CAT sits below its 50-day and 200-day moving averages ($812.93 and $805.78), and that placement is why the trend reads as down. A recovery back above the 200-day would be the first sign of repair. Just above the price, the 20-day EMA at $794.00 is the nearest level a rally would meet.
The next level below the price is the 52-week low at $510.21. With the RSI in the bearish zone, momentum still leans toward lower prices.
Technical indicators
Momentum and trend for CAT, from its daily closes.
As of October 16, 2026, with CAT at $730.69, its 14-day RSI is 32.8 (showing bearish momentum without being oversold), its 50-day simple moving average is $812.93 and its 200-day is $805.78.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What CAT moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, CAT's 1-year correlation of daily returns is +0.62 with S&P 500 (SPY), +0.61 with Nasdaq 100 (QQQ), +0.22 with Bitcoin (BTC) and +0.19 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
15 of 28 analysts rate it a buy or strong buy, 11 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $975.00 is 33.4% above the price.More buy ratings than three months ago ›
15 of 28 rate it a buy now, against 14 of 28 three months ago.
CAT Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | Citigroup | Maintains | Buy |
| Oct 5, 2026 | Truist Securities | Maintains | Buy |
| Sep 10, 2026 | Freedom Broker | Upgrade | Buy |
| Aug 11, 2026 | Evercore ISI Group | Maintains | Outperform |
| Aug 6, 2026 | DA Davidson | Maintains | Neutral |
| Aug 6, 2026 | Barclays | Maintains | Equal-Weight |
As of October 16, 2026, 28 Wall Street analysts cover CAT: 15 rate it a buy or strong buy, 11 a hold and 2 a sell or strong sell. Their 12-month price targets range from $575.00 to $1,155.00, with a median of $975.00, 33.4% above the price of $730.69.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CAT trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CAT's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CAT tends to move, against the market and on its own.
The long record
CAT's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.97% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 42.6%, from January 2018 to March 2020, regained by October 2020.Most 1-year holds ended higher ›
76% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $104,810, against $42,525 in the S&P 500 (SPY).
CAT Drawdowns & Recovery
As of October 16, 2026, CAT's worst peak-to-trough fall over the last 10 years with dividends reinvested was -42.6% (January 2018 to March 2020); it regained that peak by October 2020, 7 months after the low, and 76% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CAT in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CAT beat the S&P 500 over this period: $104,810 against $42,525.
A $10,000 investment in CAT in October 2016 would be worth about $104,810 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CAT, and which have not.
Strongest month, November: an average of +7.57%, up in 9 of 10 years.
Weakest month, March: an average of -1.49%, up in 4 of 10 years.
This month, October: has averaged +3.62%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CAT's strongest calendar month has been November (average +7.57%, up in 9 of 10 years) and its weakest March (average -1.49%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CAT, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in CAT today could grow to about $27,805 by 2036 in the base case, with a 90th-percentile outcome near $99,977 and a 10th-percentile outcome around $7,733. The simulation models price only; at today's 0.83% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
CAT Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $1,100 for CAT by 2030 in the base case, from $731 today (1.5x over 4 years). The 10th-percentile path ends near $490. These are outcomes of a Monte Carlo simulation run on CAT's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $540 | $809 | $1,213 | |
| 2028 | $506 | $897 | $1,589 | |
| 2029 | $493 | $993 | $2,002 | |
| 2030 | $490 | $1,100 | $2,471 | |
| 2031 | $493 | $1,218 | $3,012 |
Method: a lognormal simulation of CAT's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
CAT insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $542K on the open market and sold $270.0M.
As of October 16, 2026, CAT insiders reported 34 open-market sales worth $270.0M and 4 open-market purchases worth $542K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 28, 2026 | Joseph E Creed
Chief Executive Officer
|
Sell | 32.4K | $26.2M |
| Aug 28, 2026 | Joseph E Creed
Chief Executive Officer
|
Option | 44.4K | $9.8M |
| Jun 10, 2026 | James C Fish Jr
Director
|
Grant | 211 | - |
| Jun 10, 2026 | Gerald Johnson
Director
|
Grant | 211 | - |
| Jun 10, 2026 | Nazzic S Keene
Director
|
Grant | 211 | - |
| Jun 10, 2026 | David W Maclennan
Director
|
Grant | 211 | - |
| Jun 10, 2026 | Judith Fran Marks
Director
|
Grant | 211 | - |
| Jun 10, 2026 | Debra L Reed-Klages
Director
|
Grant | 211 | - |
| Jun 10, 2026 | Susan C Schwab
Director
|
Grant | 211 | - |
| Jun 10, 2026 | Rayfordjr Wilkins
Director
|
Grant | 211 | - |
| May 14, 2026 | Denise C. Johnson
Officer
|
Sell | 12.6K | $11.4M |
| May 14, 2026 | Denise C. Johnson
Officer
|
Option | 16.1K | $3.2M |
| May 13, 2026 | Denise C. Johnson
Officer
|
Sell | 6.2K | $5.6M |
| May 13, 2026 | William E Schaupp
Officer
|
Sell | 360 | $326.2K |
| May 13, 2026 | Denise C. Johnson
Officer
|
Option | 7.9K | $1.6M |
| May 11, 2026 | Anthony D. Fassino
Officer
|
Sell | 16.3K | $14.9M |
| May 11, 2026 | Anthony D. Fassino
Officer
|
Option | 21.4K | $4.7M |
| May 8, 2026 | Kyle Joseph Epley
Chief Financial Officer
|
Grant | 515 | - |
| May 6, 2026 | Lange Bob De
Officer
|
Sell | 24.2K | $22.4M |
| May 6, 2026 | Andrew Robert John Bonfield
Officer
|
Sell | 15.7K | $14.4M |
| May 6, 2026 | Anthony D. Fassino
Officer
|
Sell | 9.2K | $8.5M |
| May 6, 2026 | Andrew Robert John Bonfield
Officer
|
Option | 23.1K | $6.8M |
| May 6, 2026 | Lange Bob De
Officer
|
Option | 28.1K | $3.6M |
| May 6, 2026 | Anthony D. Fassino
Officer
|
Option | 12.0K | $2.6M |
| May 6, 2026 | Jason Kaiser
Officer
|
Grant | 294 | - |
| May 5, 2026 | Rodney Michael Shurman
Officer
|
Sell | 5.6K | $5.1M |
| May 5, 2026 | Rodney Michael Shurman
Officer
|
Option | 5.6K | $1.4M |
| May 4, 2026 | Jason Kaiser
Officer
|
Sell | 5.6K | $5.0M |
| May 4, 2026 | Jason Kaiser
Officer
|
Option | 7.9K | $2.0M |
| May 4, 2026 | David W Maclennan
Director
|
Buy | 250 | $219.2K |
| Mar 5, 2026 | Joseph E Creed
Chief Executive Officer
|
Sell | 2.5K | $1.8M |
| Mar 2, 2026 | Andrew Robert John Bonfield
Chief Financial Officer
|
Grant | 1.7K | - |
| Mar 2, 2026 | Joseph E Creed
Chief Executive Officer
|
Grant | 5.0K | - |
| Mar 2, 2026 | Lange Bob De
Officer
|
Grant | 1.7K | - |
| Mar 2, 2026 | Denise C. Johnson
Officer
|
Grant | 1.7K | - |
| Mar 2, 2026 | Jason Kaiser
Officer
|
Grant | 1.7K | - |
| Mar 2, 2026 | Derek Owens
General Counsel
|
Grant | 1.4K | - |
| Mar 2, 2026 | Christine Michael Pambianchi
Officer
|
Grant | 1.2K | - |
| Mar 2, 2026 | William E Schaupp
Officer
|
Grant | 102 | - |
| Mar 2, 2026 | Rodney Michael Shurman
Officer
|
Grant | 1.3K | - |
| Feb 23, 2026 | Rodney Michael Shurman
Officer
|
Sell | 2.3K | $1.7M |
| Feb 23, 2026 | Rodney Michael Shurman
Officer
|
Option | 2.3K | $578.6K |
| Feb 17, 2026 | Rodney Michael Shurman
Officer
|
Sell | 1.8K | $1.3M |
| Feb 17, 2026 | William E Schaupp
Officer
|
Sell | 972 | $742.8K |
| Feb 13, 2026 | Anthony D. Fassino
Officer
|
Sell | 7.9K | $6.1M |
| Feb 13, 2026 | Anthony D. Fassino
Officer
|
Option | 11.0K | $2.4M |
| Feb 12, 2026 | Jason Kaiser
Officer
|
Sell | 1.7K | $1.3M |
| Feb 11, 2026 | Lange Bob De
Officer
|
Sell | 12.5K | $9.6M |
| Feb 11, 2026 | Lange Bob De
Officer
|
Option | 15.0K | $1.9M |
| Feb 10, 2026 | Andrew Robert John Bonfield
Chief Financial Officer
|
Grant | 10.9K | - |
| Feb 10, 2026 | Joseph E Creed
Chief Executive Officer
|
Grant | 9.1K | - |
| Feb 10, 2026 | Lange Bob De
Officer
|
Grant | 9.1K | - |
| Feb 10, 2026 | Anthony D. Fassino
Officer
|
Grant | 9.1K | - |
| Feb 10, 2026 | Denise C. Johnson
Officer
|
Grant | 9.1K | - |
| Feb 10, 2026 | Jason Kaiser
Officer
|
Grant | 2.5K | - |
| Feb 10, 2026 | Derek Owens
Officer
|
Grant | 514 | - |
| Feb 10, 2026 | William E Schaupp
Officer
|
Grant | 638 | - |
| Feb 10, 2026 | Rodney Michael Shurman
Officer
|
Grant | 2.5K | - |
| Feb 10, 2026 | Donald James Umpleby III
Officer
|
Grant | 35.0K | - |
| Feb 6, 2026 | Lange Bob De
Officer
|
Sell | 22.7K | $16.3M |
| Feb 6, 2026 | Anthony D. Fassino
Officer
|
Sell | 6.0K | $4.4M |
| Feb 6, 2026 | Lange Bob De
Officer
|
Option | 28.0K | $3.9M |
| Feb 6, 2026 | Anthony D. Fassino
Officer
|
Option | 8.3K | $1.6M |
| Feb 4, 2026 | Lange Bob De
Officer
|
Sell | 16.1K | $11.3M |
| Feb 4, 2026 | Lange Bob De
Officer
|
Option | 20.0K | $2.8M |
| Feb 2, 2026 | Denise C. Johnson
Officer
|
Sell | 39.1K | $26.7M |
| Feb 2, 2026 | Lange Bob De
Officer
|
Sell | 16.0K | $10.9M |
| Feb 2, 2026 | Anthony D. Fassino
Officer
|
Sell | 10.7K | $7.3M |
| Feb 2, 2026 | Lange Bob De
Officer
|
Option | 20.5K | $3.1M |
| Feb 2, 2026 | Anthony D. Fassino
Officer
|
Option | 15.0K | $3.0M |
| Feb 2, 2026 | Denise C. Johnson
Officer
|
Option | 57.1K | $12.3M |
| Dec 31, 2025 | Andrew Robert John Bonfield
Chief Financial Officer
|
Sell | 10.0K | $5.8M |
| Dec 19, 2025 | James C Fish Jr
Director
|
Grant | 1.0K | - |
| Dec 1, 2025 | Andrew Robert John Bonfield
Chief Financial Officer
|
Sell | 10.0K | $5.7M |
| Nov 28, 2025 | Donald James Umpleby III
Officer
|
Grant | 2.4K | - |
| Nov 19, 2025 | Susan C Schwab
Director
|
Grant | 990 | - |
| Nov 11, 2025 | Jason Kaiser
Officer
|
Sell | 10.7K | $6.0M |
| Nov 11, 2025 | Jason Kaiser
Officer
|
Option | 16.9K | $3.5M |
| Nov 10, 2025 | Anthony D. Fassino
Officer
|
Sell | 8.2K | $4.7M |
| Nov 10, 2025 | Anthony D. Fassino
Officer
|
Option | 12.5K | $2.5M |
| Nov 6, 2025 | David W Maclennan
Director
|
Buy | 300 | $170.7K |
| Nov 5, 2025 | Lange Bob De
Officer
|
Sell | 14.6K | $8.2M |
| Nov 5, 2025 | William E Schaupp
Officer
|
Sell | 1.2K | $686.7K |
| Nov 5, 2025 | Lange Bob De
Officer
|
Option | 20.0K | $3.0M |
| Oct 10, 2025 | Donald James Umpleby III
Officer
|
Sell | 17.2K | $8.7M |
| Sep 22, 2025 | Donald James Umpleby III
Officer
|
Sell | 17.2K | $7.9M |
| Sep 2, 2025 | Donald James Umpleby III
Officer and Director
|
Sell | 17.2K | $7.1M |
| Aug 18, 2025 | David W Maclennan
Director
|
Grant | 500 | $203.9K |
| Aug 15, 2025 | Susan C Schwab
Director
|
Sell | 2.3K | $952.8K |
| Aug 11, 2025 | Jason Kaiser
Officer
|
Sell | 2.2K | $902.7K |
| Aug 11, 2025 | Jason Kaiser
Officer
|
Option | 4.1K | $804.7K |
| Jul 17, 2025 | Andrew Robert John Bonfield
Chief Financial Officer
|
Option | 37.5K | $8.7M |
| Jun 11, 2025 | James C Fish Jr
Director
|
Grant | 482 | $169.9K |
| Jun 11, 2025 | Gerald Johnson
Director
|
Grant | 482 | $169.9K |
| Jun 11, 2025 | Nazzic S Keene
Director
|
Grant | 482 | $169.9K |
| Jun 11, 2025 | David W Maclennan
Director
|
Grant | 482 | $169.9K |
| Jun 11, 2025 | Judith Fran Marks
Director
|
Grant | 482 | $169.9K |
| Jun 11, 2025 | Debra L Reed-Klages
Director
|
Grant | 482 | $169.9K |
| Jun 11, 2025 | Susan C Schwab
Director
|
Grant | 482 | $169.9K |
| Jun 11, 2025 | Rayfordjr Wilkins
Director
|
Grant | 482 | $169.9K |
| May 9, 2025 | Joseph E Creed
Chief Executive Officer
|
Grant | 4.3K | - |
| May 9, 2025 | Christine Michael Pambianchi
Officer
|
Grant | 2.1K | - |
| May 7, 2025 | David W Maclennan
Director
|
Buy | 375 | $120.3K |
| May 2, 2025 | Gerald Johnson
Director
|
Buy | 100 | $31.8K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.